Geoffrey Lawton

1.6k total citations
20 papers, 1.4k citations indexed

About

Geoffrey Lawton is a scholar working on Organic Chemistry, Molecular Biology and Biomaterials. According to data from OpenAlex, Geoffrey Lawton has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Biomaterials. Recurrent topics in Geoffrey Lawton's work include Protein Kinase Regulation and GTPase Signaling (5 papers), Phytochemistry and Bioactive Compounds (4 papers) and Synthesis of β-Lactam Compounds (4 papers). Geoffrey Lawton is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), Phytochemistry and Bioactive Compounds (4 papers) and Synthesis of β-Lactam Compounds (4 papers). Geoffrey Lawton collaborates with scholars based in United Kingdom and Switzerland. Geoffrey Lawton's co-authors include John Nixon, Sandra E. Wilkinson, Christopher H. Hill, Peter D. Davis, Elizabeth Keech, J. Wadsworth, D. Westmacott, Lucy H. Elliott, Steve Hurst and William R. Harris and has published in prestigious journals such as Biochemical Journal, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Geoffrey Lawton

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey Lawton United Kingdom 13 904 275 176 166 165 20 1.4k
Christopher H. Hill United Kingdom 14 960 1.1× 353 1.3× 177 1.0× 152 0.9× 122 0.7× 22 1.5k
Elizabeth Keech United Kingdom 12 721 0.8× 292 1.1× 142 0.8× 128 0.8× 68 0.4× 15 1.1k
Peter D. Davis United Kingdom 19 1.2k 1.3× 554 2.0× 177 1.0× 299 1.8× 244 1.5× 39 2.0k
Kimiko Ishiguro United States 25 822 0.9× 190 0.7× 77 0.4× 145 0.9× 251 1.5× 71 1.5k
Haile Tecle United States 14 1.1k 1.3× 423 1.5× 161 0.9× 403 2.4× 117 0.7× 27 1.7k
Allan S. Wagman United States 17 1.4k 1.5× 447 1.6× 106 0.6× 285 1.7× 217 1.3× 28 2.2k
Roland Feifel Switzerland 21 769 0.9× 338 1.2× 206 1.2× 164 1.0× 118 0.7× 36 1.3k
John L. Herrmann United States 19 582 0.6× 186 0.7× 199 1.1× 259 1.6× 146 0.9× 34 1.2k
Sébastien Sauvage Belgium 15 1.0k 1.2× 247 0.9× 88 0.5× 171 1.0× 118 0.7× 20 1.5k
Lourdes Toral‐Barza United States 28 1.9k 2.1× 514 1.9× 166 0.9× 301 1.8× 301 1.8× 41 2.6k

Countries citing papers authored by Geoffrey Lawton

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Lawton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Lawton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Lawton more than expected).

Fields of papers citing papers by Geoffrey Lawton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Lawton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Lawton. The network helps show where Geoffrey Lawton may publish in the future.

Co-authorship network of co-authors of Geoffrey Lawton

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Lawton. A scholar is included among the top collaborators of Geoffrey Lawton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Lawton. Geoffrey Lawton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bottomley, K M K, Neera Borkakoti, D. Bradshaw, et al.. (1997). Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors. Biochemical Journal. 323(2). 483–488. 32 indexed citations
2.
Broadhurst, Michael J., Paul A. Brown, Geoffrey Lawton, et al.. (1997). Design and synthesis of the cartilage protective agent (CPA, Ro32-3555). Bioorganic & Medicinal Chemistry Letters. 7(17). 2299–2302. 31 indexed citations
3.
Davis, Peter D., Trevor J. Hallam, William R. Harris, et al.. (1994). Bisindolylmaleimide inhibitors of protein kinase C. Further conformational restriction of a tertiary amine side chain.. Bioorganic & Medicinal Chemistry Letters. 4(11). 1303–1308. 9 indexed citations
4.
Bit, Rino A., Peter D. Davis, Lucy H. Elliott, et al.. (1993). Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction. Journal of Medicinal Chemistry. 36(1). 21–29. 145 indexed citations
5.
Bradshaw, D., Peter D. Davis, Lucy H. Elliott, et al.. (1992). Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitor. Inflammation Research. 37(1-2). 85–89. 9 indexed citations
6.
Davis, Peter D., Christopher H. Hill, Geoffrey Lawton, et al.. (1992). Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides. Journal of Medicinal Chemistry. 35(1). 177–184. 144 indexed citations
7.
Nixon, John, Joshua D. Bishop, D. Bradshaw, et al.. (1992). The design and biological properties of potent and selective inhibitors of protein kinase C. Biochemical Society Transactions. 20(2). 419–425. 64 indexed citations
8.
Davis, Peter D., Lucy H. Elliott, William R. Harris, et al.. (1992). Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity. Journal of Medicinal Chemistry. 35(6). 994–1001. 199 indexed citations
9.
Dale, M.Maureen, Peter D. Davis, Lucy H. Elliott, et al.. (1991). A novel conformationally restricted protein kinase C inhibitor, Ro 31‐8425, inhibits human neutrophil superoxide generation by soluble, particulate and post‐receptor stimuli. FEBS Letters. 293(1-2). 169–172. 52 indexed citations
10.
Bradshaw, D., E. J. Lewis, Joshua D. Bishop, et al.. (1991). Oral anti-inflammatory activity of a potent, selective, protein kinase C inhibitor. International Journal of Immunopharmacology. 13(6). 749–749. 1 indexed citations
11.
Bradshaw, D., et al.. (1991). Novel, potent and selective inhibitors of protein kinase C show oral anti-inflammatory activity.. PubMed. 17(8). 389–93. 20 indexed citations
12.
Nixon, John, K M K Bottomley, Michael J. Broadhurst, et al.. (1991). Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.. PubMed. 13(5). 237–41. 41 indexed citations
13.
Elliott, Lucy H., Sandra E. Wilkinson, Christopher H. Hill, et al.. (1990). K252a is a potent and selective inhibitor of phosphorylase kinase. Biochemical and Biophysical Research Communications. 171(1). 148–154. 59 indexed citations
14.
Davis, Peter D., Christopher H. Hill, Elizabeth Keech, et al.. (1989). Potent selective inhibitors of protein kinase C. FEBS Letters. 259(1). 61–63. 439 indexed citations
15.
Lawton, Geoffrey, et al.. (1987). Synthesis of 1,2-diazetidinones (aza-β-lactams) by photochemical ring contraction. Journal of the Chemical Society Perkin Transactions 1. 877–884. 7 indexed citations
16.
Lawton, Geoffrey, et al.. (1987). Rhodium carbenoid mediated cyclisations. Synthesis of 1,2-diazetidinones (aza-β-lactams). Journal of the Chemical Society Perkin Transactions 1. 899–902. 10 indexed citations
17.
Hassall, Cedric H., et al.. (1986). The design and synthesis of the Angiotensin Converting Enzyme inhibitor Cilazapril and related bicyclic compounds. Journal of the Chemical Society Perkin Transactions 1. 1011–1019. 76 indexed citations
18.
Moody, Christopher J., et al.. (1985). Regioselectivity in the photochemical ring contraction of 4-diazopyrazolidine-3,5-diones to give aza-β-lactams. Tetrahedron Letters. 26(26). 3167–3170. 7 indexed citations
19.
Moody, Christopher J., et al.. (1985). Synthesis of aza-β-lactams by rhodium carbenoid mediated cyclisation. Tetrahedron Letters. 26(26). 3171–3172. 10 indexed citations
20.
Hassall, Cedric H., Antonin Kröhn, Geoffrey Lawton, et al.. (1984). New potent inhibitors of angiotensin converting enzyme. FEBS Letters. 165(2). 201–206. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher H. Hill Breakdown of academic impact, for papers by Elizabeth Keech Breakdown of academic impact, for papers by Peter D. Davis Breakdown of academic impact, for papers by Kimiko Ishiguro Breakdown of academic impact, for papers by Haile Tecle Breakdown of academic impact, for papers by Allan S. Wagman Breakdown of academic impact, for papers by Roland Feifel Breakdown of academic impact, for papers by John L. Herrmann Breakdown of academic impact, for papers by Sébastien Sauvage Breakdown of academic impact, for papers by Lourdes Toral‐Barza
Rankless by CCL
2026